Cowen to host 41st Annual Health Care Conference on March 1-4, 2021. Click here for more information.

$2.1 Billion

CM Life Sciences

Buy-side

Capital Markets Advisor, February 2021

Combination with Sema4

CM Life Sciences, Inc. is a blank check company incorporated in July 2020 as a Delaware corporation and formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses or entities. CMLF’s sponsor is an affiliate of Eli Casdin, founder and Chief Investment Officer of Casdin Capital, and of Keith Master, founder and Chief Investment Officer at Corvex Management, two leading investment firms.

Sema4 operates as a patient-centered health intelligence Company focused on delivering deeper analysis and increased engagement to facilitate improvement in the diagnosis, treatment, and prevention of diseases. The Company's proprietary platform breaks through the limitations of existing technologies and effectively democratizes health information, enabling clients to accelerate basic science research and significantly improve the speed and success rate of therapeutic development.

More Like This

Jan 2021
$31 Million

Acquisition of UPRIGHT Technologies Ltd.

Financial Advisor

View Details
Dec 2020
$106 Million
Alphatec Holdings

Acquisition of EOS Imaging SA

Exclusive Financial Advisor

View Details
Dec 2020
$45 Million

Merger with Neos Therapeutics, Inc.

Exclusive Financial Advisor

View Details